Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina
Fernandez-Bueno, I, Garcia-Gutierrez, M T, Srivastava, G K, Gayoso, M J, Gonzalo-Orden, J M, Pastor, J C
Published in Molecular vision (17.04.2013)
Get full text
Published in Molecular vision (17.04.2013)
Journal Article
Effects of plasma kallikrein inhibitors in an in vitro RPE oxidative stress model
Alonso‐Alonso, M.L., Hampton, S.L., Williams, J.L., García‐Gutiérrez, M.T., Fernández‐Bueno, I., Srivastava, G.K., Pastor, J.C., Diebold, Y.
Published in Acta ophthalmologica (Oxford, England) (01.09.2017)
Published in Acta ophthalmologica (Oxford, England) (01.09.2017)
Get full text
Journal Article